The first human clinical trial using CRISPR/Cas9 gets approval from the National Institutes of Health. The approved proposal will use the gene-editing tool to target three different types of cancer.
Federal Panel Approves First Human Clinical Trial For Controversial Gene-Editing Tool CRISPR
Tech Times - 22 Jun 2016 16:00
The first human clinical trial using CRISPR/Cas9 gets approval from the National Institutes of Health. The approved proposal will use the gene-editing tool to target three different types of cancer.
Share this Article
Recommended